Obstructive Sleep Apnea (OSA) Drugs MarketPosted by ahila on April 26th, 2018 Global Obstructive Sleep Apnea (OSA) Drugs Market is a common type of sleep apnea which is characterized by the frequent cessation in breathing in deep sleep which can be occurred during the relaxation of muscles in the back of throat blocking the airway. These muscles help in supporting pharyngeal and oral structures such as uvula, soft palate, tonsils and tongue. Usually, 10-20 minutes of pausing in breathing if the airway is either partially or completely blocked that can lower the blood oxygen levels. The brain gets panic when this happens and rouses body to restart breathing. It can happen about 30 times an hour throughout the midnight which significantly disturbs the sleep cycles. A surge in the prevalence of sleep apnea is majorly driving the growth of the sleep apnea treatment market. As per the National Commission on Sleeping Disorders Research, globally about 38,000 deaths are accounting annually owing to the cardiovascular problems associated with sleep apnea. Furthermore, growing geriatric population, rising lifestyle changes, growing home care acceptance coupled with the awareness of sleep disorders, improving healthcare infrastructure, an introduction of new technologies and innovative products are expected to fuel the growth of sleep apnea treatment market. However, strict regulatory procedures, side effects associated with the drugs, high competition in the market are expected to hamper the sleep apnea treatment market growth. A sample of this report is available upon request @ The obstructive sleep apnea (OSA) drugs market is classified on the basis of drugs, distribution channel, and geography. Based on drugs, the obstructive sleep apnea drugs market is segmented into the following:
Based on distribution channel, the obstructive sleep apnea drugs market is segmented into the following:
To view TOC of this report is available upon request @ Like it? Share it! More by this author |